20
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Effect of Pranlukast, a Leukotriene Receptor Antagonist, in Patients with Severe Asthma Refractory to Corticosteroids

, , , , &
Pages 57-62 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kazuhiro Ito & Nicolas Mercado. (2009) Therapeutic targets for new therapy for corticosteroid refractory asthma. Expert Opinion on Therapeutic Targets 13:9, pages 1053-1067.
Read now
Luis García-Marcos & Antje Schuster. (2001) Antileukotrienes in asthma: present situation. Expert Opinion on Pharmacotherapy 2:3, pages 441-466.
Read now

Articles from other publishers (14)

Andreanne Côté, Richard J. Russell, Louis-Philippe Boulet, Peter G. Gibson, Kefang Lai, Richard S. Irwin, Christopher E. Brightling, Kenneth W. Altman, Elie Azoulay, Alan F. Barker, Fiona Blackhall, Donald C. Bolser, Surinder S. Birring, Sidney S. Braman, Christopher Brightling, Priscilla Callahan-Lyon, Anne B. Chang, Terrie Cowley, Paul Davenport, Ali A. El Solh, Patricio Escalante, Stephen K. Field, Dina Fisher, Cynthia T. French, Cameron Grant, Peter Gibson, Susan M. Harding, Anthony Harnden, Adam T. Hill, Richard S. Irwin, Peter J. Kahrilas, Joanne Kavanagh, Kefang Lai, Andrew P. Lane, Craig Lilly, Mark Lown, J. Mark Madison, Mark A. Malesker, Stuart Mazzone, Lorcan McGarvey, Alex Molasoitis, Abigail Moore, M. Hassan Murad, Mangala Narasimhan, John Oppenheimer, Mark Rosen, Bruce Rubin, Richard J. Russell, Jay H. Ryu, Sonal Singh, Jaclyn Smith, Maeve P. Smith, Susan M. Tarlo, Anne E. Vertigan & Miles Weinberger. (2020) Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents. Chest 158:1, pages 68-96.
Crossref
Stacy Gelhaus Wendell, Hao Fan & Cheng Zhang. (2019) G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action. Pharmacological Reviews 72:1, pages 1-49.
Crossref
Robin F Pokrzywinski, David M Meads, Stephen P McKenna, G Alistair Glendenning & Dennis A Revicki. (2009) Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS). Health and Quality of Life Outcomes 7:1.
Crossref
Antoine Caubel, Nicolas Roche & Gérard Huchon. (2004) Traitement de l'asthme. EMC - Pneumologie 1:1, pages 1-12.
Crossref
Luis Garc??a-Marcos, Antje Schuster & Eduardo G P??rez-Yarza. (2003) Benefit-Risk Assessment of Antileukotrienes in the Management of Asthma. Drug Safety 26:7, pages 483-518.
Crossref
Jeffrey M. Drazen. 2003. Advances in Prostaglandin, Leukotriene, and other Bioactive Lipid Research. Advances in Prostaglandin, Leukotriene, and other Bioactive Lipid Research 1 5 .
Phillip E. Korenblat. (2001) The role of antileukotrienes in the treatment of asthma. Annals of Allergy, Asthma & Immunology 86:6, pages 31-39.
Crossref
Setsuo Furuta, Seichi Tanigawa, Hiroshi Ohmizo & Hiroshi Iwama. (2001) Increase of peak expiratory flow by atropine is dependent on circadian rhythm. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 48:1, pages 85-87.
Crossref
David M Lang. (2000) Antileukotriene agents and aspirin-sensitive asthma: are we removing the second bassoonist or skating to where the puck is gonna be?. Annals of Allergy, Asthma & Immunology 85:1, pages 5-8.
Crossref
Girish Gupta. (2000) Anti-leukotrienes in asthma: Yet to arrive. The Indian Journal of Pediatrics 67:2, pages 113-117.
Crossref
Stephen C. Weisberg. (2000) Pharmacotherapy of asthma in children, with special reference to leukotriene receptor antagonists. Pediatric Pulmonology 29:1, pages 46-61.
Crossref
PHILIPPE DEVILLIER, NATHALIE BACCARD & CHARLES ADVENIER. (1999) LEUKOTRIENES, LEUKOTRIENE RECEPTOR ANTAGONISTS AND LEUKOTRIENE SYNTHESIS INHIBITORS IN ASTHMA: AN UPDATE. PART II: CLINICAL STUDIES WITH LEUKOTRIENE RECEPTOR ANTAGONISTS AND LEUKOTRIENE SYNTHESIS INHIBITORS IN ASTHMA. Pharmacological Research 40:1, pages 15-29.
Crossref
A. Magnan & D. Vervloet. (1999) Anti-leucotriènes (3) : leur place dans le traitement de l'asthme. Revue Française d'Allergologie et d'Immunologie Clinique 39:7, pages 546-550.
Crossref
Douglas W. P. Hay. 1999. Novel Inhibitors of Leukotrienes. Novel Inhibitors of Leukotrienes 317 341 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.